Navigation Links
Hard To Treat Diseases (HTDS) Completes E Europe Merger
Date:1/5/2009

CLEARWATER, FL, Jan. 5 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com Further to the company's various merger updates where amongst other things the company addressed several targeted merger candidates, the company is pleased to announce that it has finalized its bilateral negotiations with Slavica Bio Chem, www.slavicabiochem.com (Slavica).

Slavica Bio Chem is a spin off of Renuyu Biochem, a USA and a UK company, founded by Andrea Zecevic. Andrea currently acts as a head scientific advisor to HTDS. The company research and development dates back to 2005. The institute and the physical plant is located in Belgrade Serbia. The company has been completely self funding with private resources since its inception. Over the next several weeks Slavica management and its officers intend to provide a series of filings and updates on the company's efforts and progress in this field.

Under the agreement the medical team will receive payment in stock and options on HTDS security on a delivery and performance based schedule. Consideration for Slavica is 300 million non-dilatable restricted shares to be distributed amongst all doctors involved in Belgrade Serbia research. Andrea Zecevic, as a vote of confidence in Slavica and who spearheaded the transaction, shall receive no stock in this transaction and in lieu will take stock options at a .03c strike price for up to 9% of the company common stock.

In other corporate news, the company representatives intend to visit mainland China for a second merger company discussions with a China based company in a similar field and research as Slavica with a significant operations already in place in China. Upon completion of the China merger, the company intends to name its new CEO, officers and directors consisting primarily of medical professionals and business consulta
'/>"/>

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Molecular imaging enables earlier, individualized treatment of thyroid cancer
2. Family history of prostate cancer does not affect some treatment outcomes
3. Errors involving medications common in outpatient cancer treatment
4. Hard To Treat Diseases (HTDS) Operational Update
5. Cancer drug effectively treats transplant rejections
6. Childhood anxiety disorders can and should be treated, according to UT Southwestern national expert
7. Treating gum disease linked to lower medical costs for patients with diabetes
8. Study: How Can States Treat a Sick Economy? Call the Doctors
9. Groundbreaking, inexpensive, pocket-sized ultrasound device can help treat cancer, relieve arthritis
10. Holiday Treats and Decorations Can Be a Deadly Combination for Pets
11. New study shows that a cough medicine ingredient could effectively treat prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and a ... received the Music & Memory Certification for hospice patients and adult day center participants. ... not only to patients but also to their families and volunteers. Music & Memory ...
(Date:7/5/2015)... ... , ... City Sports, the Boston-based specialty sporting goods retailer, has renewed their ... triathletes this summer with ethos, the owner and operator of the Boston Triathlon. , ... p.m. at the North End Greenway. The event will help new triathletes prepare for ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special ... months of unlimited classes for just $65. Student ID is needed at registration. , ... in Lake Orion. , Women’s Excellence is the most comprehensive obstetric ...
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in 2015, ... of an annual member survey , detailing the most common plastic surgery and ... broke that raw data down into charts detailing demographic trends and regional preferences. ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler ... recognition of technical sales expertise from the North American Board of Certified Energy ... is the most highly respected and well established national certification organization for renewable ...
Breaking Medicine News(10 mins):Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3
... finds , MONDAY, Dec. 7 (HealthDay News) A new ... in preventing dangerous venous clots as an old standby, warfarin, ... new study finds. , Dabigatran is marketed as Pradax in ... for use in the United States. , The new study, ...
... ... top-of-the-line implementation services to Talyst’s clients in the acute care industry. , ... (PRWEB) December ... the American Society of Health-System Pharmacists in Las Vegas, Talyst announced a partnership ...
... Dec. 7 Hoping to protect their children and grandchildren ... are prepared to make the difficult choices necessary to put ... clear in a report released today by The Concord Coalition ... by a grant from the Peter G. Peterson Foundation, the ...
... , ... 7 Stand Up To Cancer (SU2C) announced today that ... conducted by 13 young scientists. Over a three-year period, each ... part of SU2C,s Innovative Research Grants program, which supports the ...
... , NEW ORLEANS, Dec. 7 Micromet, ... novel, proprietary antibodies for the treatment of cancer, inflammation ... poster(1) with new data from its ongoing phase 1 ... with non-Hodgkin,s lymphoma (NHL) at the 51ST Annual Meeting ...
... , WALTHAM, Mass., Dec. 7 Interleukin Genetics, Inc. ... approval by the State of New York,s Department of Health ... Genetic Test that determines predisposition to severe periodontal disease in ... States in the U.S. However, through its Clinical Laboratory ...
Cached Medicine News:Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:Talyst and RXinnovate Partner on Pharmacy Automation Implementation 2Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 2Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 2Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 3
(Date:7/2/2015)... -- According to a new market research report ... Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, ... by MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 ... by 2020, at a CAGR of 11.2% during the forecast ... market data T ables and ...
(Date:7/2/2015)... Numotion,s Board of Directors and Mike ... Feitel has joined the Company as Chief Financial ... successful 18 year career at GE serving in executive ... productivity to result in significant industry leading growth and ... Officer for GE Healthcare Global Services, a $5B P&L ...
(Date:7/2/2015)... 25, 2015 ... the addition of the "2015 New ... Challenges, Emerging Technologies, Competitive Landscape" report ... Frontiers in Clinical Chemistry and Immunodiagnostics: Global ... new seven-country strategic analysis of major business ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Numotion Names Tamas Feitel Chief Financial Officer 2New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... ... ... ... ...
... , ... ... ... ...
Cached Medicine Technology:STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 2STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 3STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 4STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 5STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 6STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 7STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 8STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 9STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 10STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 11STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 12STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 13STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 14STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 15STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 16STELARA(TM) and REMICADE(R) Data in Treatment of Plaque Psoriasis to be Presented at American Academy of Dermatology (AAD) Meeting 17Orexigen(R) Therapeutics Schedules March 9, 2010 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2009 2Orexigen(R) Therapeutics Schedules March 9, 2010 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2009 3
... 200 to 350 Liters of pure water, ... Distribution of Purified Water,Millipores compact S.D.S. Storage ... 200 to 350 liters of purified water ... to maintain consistent purity of stored water, ...
... 200 to 350 Liters of pure water, ... Distribution of Purified Water,Millipores compact S.D.S. Storage ... 200 to 350 liters of purified water ... to maintain consistent purity of stored water, ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
Medicine Products: